InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,221.92
(
0.01%
)
US TECH 100
17,739.20
(
0.09%
)
Dow Jones
39,416.93
(
-0.04%
)
Brent Oil
81.96
(
-1.51%
)
Bitcoin
61,673.52
(
-1.96%
)
Post# of 10798
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

RNsidersbuying

Send PM Follow Ignore
Followers 46
Posts 4459
Boards Moderated 0
Alias Born 07/26/2010

RNsidersbuying

Re: rocketeer357 post# 10687

Monday, 03/02/2020 8:11:16 AM

Monday, March 02, 2020 8:11:16 AM

Post# of 10798
NBIO .125 - The only company with a target for vimentim is Nascent Biotech Inc. (OTCMKT: NBIO). Their lead candidate is pritumumab which was a phase 2 brain cancer asset in Japan. They have redone their cell line for study and on the cusp of starting their phase 1 cancer trial.

https://insiderfinancial.com/top-coronavirus-stocks-backed-by-scientific-evidence/179657/
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up